NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 243 filers reported holding NEOGENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,900 | -46.0% | 3,000 | -29.4% | 0.03% | -39.2% |
| Q2 2023 | $68,298 | +30.8% | 4,250 | +41.7% | 0.05% | +24.4% |
| Q1 2023 | $52,230 | +76.6% | 3,000 | -6.2% | 0.04% | +86.4% |
| Q4 2022 | $29,568 | +28.6% | 3,200 | +18.5% | 0.02% | +10.0% |
| Q3 2022 | $23,000 | +4.5% | 2,700 | 0.0% | 0.02% | +11.1% |
| Q2 2022 | $22,000 | +46.7% | 2,700 | +125.0% | 0.02% | +80.0% |
| Q1 2022 | $15,000 | -63.4% | 1,200 | 0.0% | 0.01% | -61.5% |
| Q4 2021 | $41,000 | -71.5% | 1,200 | -59.8% | 0.03% | -75.5% |
| Q3 2021 | $144,000 | +15.2% | 2,988 | +8.0% | 0.11% | +15.2% |
| Q2 2021 | $125,000 | +594.4% | 2,767 | +641.8% | 0.09% | +557.1% |
| Q1 2021 | $18,000 | +5.9% | 373 | +18.0% | 0.01% | -6.7% |
| Q4 2020 | $17,000 | -79.5% | 316 | -85.9% | 0.02% | -80.0% |
| Q3 2020 | $83,000 | +1085.7% | 2,249 | +848.9% | 0.08% | +837.5% |
| Q2 2020 | $7,000 | – | 237 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |